Skip to main content

PhD Partnership Program

The Program awards funding for projects in which PhD candidates can undertake research within the pharmaceutical and biological therapeutics sectors.

ProCan laboratory at Children's Medical Research Institute

NSW Health’s PhD Partnership Program provides funding for research projects designed for PhD candidates to develop skills and experience within the pharmaceutical and biological therapeutics sectors under the joint supervision of academic and industry supervisors.

The objectives of the Program are to:

  • promote collaboration between industry and university researchers
  • build commercialisation capacity in the pharmaceutical and biological therapeutics sector
  • increase the number of locally developed therapeutics reaching Phase I clinical trials
  • create new opportunities for PhD students to study the development of novel therapeutics
  • ensure graduates leave university with the skills necessary to succeed in industry
  • improve graduate understanding of the diversity of employment opportunities in the NSW pharmaceutical and biological therapeutics sectors.

Applications for the last round of funding closed in November 2019.

Details about the next round of funding will be advertised on this page and through other channels when available. To ensure you receive the latest news and notifications regarding this and other programs, please subscribe to our mailing list at the bottom of this page.

Eligible research areas

Scholarships will be targeted at pre-clinical research with an identified therapeutic target, with a view to readying novel therapeutics for Phase I clinical trials. Eligible areas of research include but are not limited to:

  • fragment-based and/or high-throughput lead discovery
  • lead optimisation
  • pharmacodynamics and pharmacokinetics (including absorption, distribution, metabolism and excretion)
  • medicinal chemistry
  • chemistry and antibody design
  • manufacturing
  • formulation and the development of drug delivery platforms
  • efficacy and proof-of-concept
  • acute toxicology
  • gene vector design and manufacture
  • therapeutic applications of macromolecules
  • pre-clinical models, including cell and animal trials.

For areas of research that do not appear above, applicants may present a justification as to why the proposed project is a priority in NSW and should be funded.

Frequently asked questions

  • PhD Partnerships Program

Past recipients

The research directory lists all research projects and/or devices that have received funding through the Office for Health and Medical Research.